Las Vegas, NV -- (SBWIRE) -- 12/18/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: YRC Worldwide, Inc. (NASDAQ:YRCW), Hanwha Solarone Co Ltd (NASDAQ:HSOL), Vringo, Inc. (NASDAQ:VRNG), Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
YRC Worldwide, Inc. (NASDAQ:YRCW) managed to keep its gain at 7.20% on above-normal volume of 2.90M shares. The stock settled at $1.3.99 after floating in a range of $12.05 to $14.19. Its latest price has reached market capitalization of $142.65 million. Its 52-week range has been $5.75 to $36.99. Weyerhaeuser Company, a forest products company, grows and harvests trees, builds homes, and manufactures forest products worldwide. It grows and harvests trees for use as lumber, other wood and building products, and pulp and paper. The company manages 6.4 million acres of private commercial forestland; and has long-term licenses on 13.9 million acres of forestland.
For How Long YRCW will fight for Profitability? Read This Trend Analysis report
Hanwha Solarone Co Ltd (NASDAQ:HSOL) traded up on a volume of 2.46 million, higher than its standard daily volume. Shares have gained 7.54% to $2.71. Over the last twelve months, the stock has gained 185.26% and faced a worst price of $0.86. Hanwha SolarOne Co., Ltd. (Hanwha SolarOne) is an integrated manufacturer of silicon ingots, silicon wafers, PV cells and PV modules in China. The Company manufactures a range of silicon ingots, silicon wafers, Photovoltaic (PV) cells and PV modules using advanced manufacturing process technologies that have helped the Company to increase its operational efficiency. The Company also provides PV module processing services.
For How Long HSOL’s Gloss will Attract Investors? Find out via this report
Vringo, Inc. (NASDAQ:VRNG) settled -1.62% lower at $3.03 on above-normal volume of 2.33M shares during the last trading day. The stock has its 12-month high at $3.90 and 52-week low price was $2.61. It traded in a range of $3.03 to $3.25 during the last trading day. Vringo, Inc. (Vringo) is a development-stage company. The Company is engaged in developing software for mobile phones. It provides a platform, which allows users to create, download and share mobile entertainment content in the form of video ringtones for mobile phones. Vringo’s product consists of four components, such as The Vringo Mobile Application,
Will VRNG Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Synta Pharmaceuticals Corp. (NASDAQ:SNTA) was down on low volume, trading at a volume of 2.15M versus its average daily volume of 2.22 million shares. At $4.30, the stock has attained market capitalization of 366.37 million. Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases. As of December 31, 2011, it had two drug candidates in clinical trials for treating multiple types of cancer and several drug candidates in the preclinical-stage of development.
Why Should Investors Buy SNTA After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)